학술논문
P640: PIRTOBRUTINIB, A HIGHLY SELECTIVE, NON-COVALENT (REVERSIBLE) BTK INHIBITOR IN COMBINATION WITH VENETOCLAX±RITUXIMAB IN RELAPSED/REFRACTORY CLL: RESULTS FROM THE BRUIN PHASE 1B STUDY
Document Type
article
Author
Source
HemaSphere, Vol 6, Pp 538-539 (2022)
Subject
Language
English
ISSN
2572-9241